Tumor-Induced Myeloid Dysfunction and Its Implications for Cancer Immunotherapy
Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-014-1639-3
Full Text
Open PDFAbstract
Available in full text
Date
November 29, 2014
Authors
Publisher
Springer Science and Business Media LLC